Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-021919

Chief Executive Officer sold 14,683 shares at $214.25 ($3,145,905)

  • Chief Executive Officer acquired 14,683 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-07 Exercise or conversion : show line 1 in the form 10b5-1 +14,683 $84.98 $1,247,761 455,482 D
2024-08-07 Sale : show line 2 in the form 10b5-1 −14,683 $214.25 $3,145,905 440,799 D
Open-market sales · 14,683 sh · avg $214.25 · $3,145,905

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-07 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −14,683 44,049 D
Loading xslF345X05/form4.xml…